ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Suxinutin®:Pfizer AG
Vollst. FachinformationDDDDrucken 
Gal.Form/Ther.Gr.Zusammens.Eigensch.Pharm.kinetikInd./Anw.mögl.Dos./Anw.Anw.einschr.Unerw.Wirkungen
Interakt.Überdos.Sonstige H.Swissmedic-Nr.Stand d. Info. 
N03AD01 - EthosuximideATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N03 - Antiepileptics
 
N03A - Antiepileptics

This group comprises preparations used in the treatment of epilepsy and related conditions (e.g. seizures).
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

The DDDs for the antiepileptics are based on combination therapy.

N03AD - Succinimide Derivatives
 
N03AD01 - Ethosuximide
StärkeAdm.RouteNote
 O 
2025 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home